Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Sources
sec edgar · verbatim disclosureEach tie, with the sentence that disclosed it. Open a row for the wording and the filing it came from.
“For the year ended December 31, 2025, approximately 53% of our net revenues were attributable to three customers.”
$468M relationship
basisANIP fy2025 · closed 2025-12 $883M
FILING10-K0001023024-26-000014cik 0001023024
“During the years ended December 31, 2025 and 2024, 17% and 12%, respectively, of our raw material inventory purchases were from one domestic supplier.”
$150M relationship
basisANIP fy2025 · closed 2025-12 $883M
FILING10-K0001023024-26-000014
“The Company will also pay royalties to EyePoint from 2025 to 2028 at 30% of annual U.S. net sales of certain products (including YUTIQ and ILUVIEN) in excess of certain thresholds, beginning at $70.0 million in 2025, and increasing annually thereafter.”
FILING10-K0001023024-26-000014cik 0001023024
“We pay to Merck Sharpe & Dohme B.V. ("Merck") quarterly contingent consideration in the form of a perpetual, tiered royalty expressed as a percentage of Cortrophin Gel net sales.”
FILING10-K0001023024-26-000014cik 0001023024
“We conduct business with the three major wholesalers in the U.S.: Cencora, Inc., Cardinal Health, and McKesson.”
FILING10-K0001023024-26-000014cik 0001023024
“We conduct business with all the major retail chains in the U.S. including CVS, Kroger, Walmart, and Walgreens among others.”
FILING10-K0001023024-26-000014cik 0001023024
“We conduct business with all the major retail chains in the U.S. including CVS, Kroger, Walmart, and Walgreens among others.”
FILING10-K0001023024-26-000014cik 0001023024
“We conduct business with the three major wholesalers in the U.S.: Cencora, Inc., Cardinal Health, and McKesson.”
FILING10-K0001023024-26-000014cik 0001023024
“We conduct business with all the major retail chains in the U.S. including CVS, Kroger, Walmart, and Walgreens among others.”
FILING10-K0001023024-26-000014cik 0001023024
“We conduct business with the three major wholesalers in the U.S.: Cencora, Inc., Cardinal Health, and McKesson.”
FILING10-K0001023024-26-000014cik 0001023024
“We conduct business with all the major retail chains in the U.S. including CVS, Kroger, Walmart, and Walgreens among others.”
FILING10-K0001023024-26-000014cik 0001023024
“We contract with specialty pharmacies, such as CVS Specialty Pharmacy, Accredo Specialty Pharmacy, ASD Specialty Healthcare, Optum Specialty Pharmacy, and others to dispense our Rare Disease products, including Cortrophin Gel.”
FILING10-K0001023024-26-000014cik 0001023024
“We have contracts with several major distributors in the U.S., including Anda, Smith Drug Company, Morris Dickson, CVS Caremark, Accredo, OptumRx, CuraScript and several other partners.”
FILING10-K0001023024-26-000014cik 0001023024
“We contract with specialty pharmacies, such as CVS Specialty Pharmacy, Accredo Specialty Pharmacy, ASD Specialty Healthcare, Optum Specialty Pharmacy, and others to dispense our Rare Disease products, including Cortrophin Gel.”
FILING10-K0001023024-26-000014cik 0001023024
“We have contracts with several major distributors in the U.S., including Anda, Smith Drug Company, Morris Dickson, CVS Caremark, Accredo, OptumRx, CuraScript and several other partners.”
FILING10-K0001023024-26-000014cik 0001023024
“We have contracts with several major distributors in the U.S., including Anda, Smith Drug Company, Morris Dickson, CVS Caremark, Accredo, OptumRx, CuraScript and several other partners.”
FILING10-K0001023024-26-000014cik 0001023024
“We contract with specialty pharmacies, such as CVS Specialty Pharmacy, Accredo Specialty Pharmacy, ASD Specialty Healthcare, Optum Specialty Pharmacy, and others to dispense our Rare Disease products, including Cortrophin Gel.”
FILING10-K0001023024-26-000014cik 0001023024
“We have contracts with several major distributors in the U.S., including Anda, Smith Drug Company, Morris Dickson, CVS Caremark, Accredo, OptumRx, CuraScript and several other partners.”
FILING10-K0001023024-26-000014cik 0001023024
“We contract with specialty pharmacies, such as CVS Specialty Pharmacy, Accredo Specialty Pharmacy, ASD Specialty Healthcare, Optum Specialty Pharmacy, and others to dispense our Rare Disease products, including Cortrophin Gel.”
FILING10-K0001023024-26-000014cik 0001023024
“We have contracts with several major distributors in the U.S., including Anda, Smith Drug Company, Morris Dickson, CVS Caremark, Accredo, OptumRx, CuraScript and several other partners.”
FILING10-K0001023024-26-000014cik 0001023024
“We have contracts with several major distributors in the U.S., including Anda, Smith Drug Company, Morris Dickson, CVS Caremark, Accredo, OptumRx, CuraScript and several other partners.”
FILING10-K0001023024-26-000014cik 0001023024
“We license one utility patent right relating to the YUTIQ injector from EyePoint Pharmaceuticals US, Inc. (f/k/a pSivida US, Inc. or "EyePoint").”
FILING10-K0001023024-26-000014cik 0001023024
“We have contracts with group purchasing organizations in the U.S., including ClarusONE, Walgreens Boots Alliance Development Group, Red Oak Sourcing, Econdisc, Optisource, Rx Sourcing Strategies, The Premier Group, Topco, The Buyer's Consortium, Managed Health Care Associates Inc., Asembia, and Premier Inc., among others.”
FILING10-K0001023024-26-000014cik 0001023024
“We have contracts with group purchasing organizations in the U.S., including ClarusONE, Walgreens Boots Alliance Development Group, Red Oak Sourcing, Econdisc, Optisource, Rx Sourcing Strategies, The Premier Group, Topco, The Buyer's Consortium, Managed Health Care Associates Inc., Asembia, and Premier Inc., among others.”
FILING10-K0001023024-26-000014cik 0001023024
Watchlist prices, news filtered to it, and its next report on your desk.
ANI Pharmaceuticals Inc
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Pharmaceutical Preparations
Prev close 71.52 · gapped below the open, then crossed back over prior close. High/low 71.54 at 1:45 pm ET, 70.42 at 9:45 am ET.
ANI Pharmaceuticals Inc has 4 disclosed suppliers and 29 disclosed customers. Each one is named in an SEC filing, either ANI Pharmaceuticals Inc’s own annual report or the counterparty’s, and carries the sentence that discloses it.
ANIP (ANI Pharmaceuticals Inc) has 4 disclosed suppliers and 29 disclosed customers, strongest disclosure first.
Suppliers:
Customers:
Select a tie for the filing sentence that discloses it; select again to open the company. Lines are disclosed suppliers and customers, coloured by industry; the closer to the centre, the more the filings disclose. A dot is green or red by today’s move, and a bundle sits past the rings until you open it. Extended: satellites hang off single companies, not bundled sectors.
Largest move on the map today: EYPT −12.94%, in healthcare.